STOCK OPTIONS AND WARRANTS (Details 4) - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2022 |
Sep. 30, 2022 |
|
| Exercisable, Number of Options | 866,766 | 848,559 |
| Warrants Exercisable [Member] | ||
| Weighted average remaining life in years | 2 years 4 months 24 days | |
| Exercisable, Number of Options | 333,855 | |
| Exercise price | $ 5.06 | |
| Warrants Outstanding [Member] | ||
| Weighted average remaining life in years | 2 years 4 months 24 days | |
| Number of outstanding | 333,855 | |
| 5.06 [Member] | Warrants Exercisable [Member] | ||
| Weighted average remaining life in years | 2 years 4 months 24 days | |
| Exercisable, Number of Options | 333,855 | |
| Exercise price | $ 5.06 | |
| 5.06 [Member] | Warrants Outstanding [Member] | ||
| Weighted average remaining life in years | 2 years 4 months 24 days | |
| Number of outstanding | 333,855 |
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|